Sam Altman, already having a bad start to his week as a Chinese chatbot has put into doubt the lead of U.S. AI startups, is ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
DeepSeek is a Hangzhou-based startup whose controlling shareholder is Liang Wenfeng, cofounder of quantitative hedge fund ...
Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...